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17BETA-ESTRADIOL-INDUCED UP-REGULATION OF TYPE II COLLAGEN
EXPRESSION IS MEDIATED BY ER ALPHA/SP/SOX-9/P300 COMPLEX
THROUGH COL2A1 PROMOTER/FIRST INTRON INTERACTIONS IN
DIFFERENTIATED AND DEDIFFERENTIATED ARTICULAR CHONDROCYTES
L. Maneix1, N. Boujrad2, G. Flouriot2, M. Demoor1, K. Boumediene1,
S. Moslemi1, P. Galera1
1Lab. of Extracellular Matrix and Pathology, Caen, France; 2Lab. of Molecular
Endocrinology of Reproduction, CNRS UMR 6026, Rennes, France
Purpose: Type II collagen, encoded by COL2A1 gene, is a phenotypic
marker of articular cartilage whose expression is strongly decreased during
osteoarthritis (OA) process. Speciﬁc proteins (Sp) and Sox proteins have
been previously characterized to be major regulators of this gene. Besides,
the existence of a link between estrogen deprivation and osteoarthritis
in postmenopausal women suggests that 17β-estradiol (17β-E2) may be a
critical modulator of cartilaginous matrix homeostasis. The aim of present
study was to investigate the molecular mechanisms regulating type II
collagen gene expression under the effect of 17β-E2, and to characterize the
genomic pathway via estrogen receptors (ER).
Methods: Articular chondrocytes were isolated from 3-week old rabbits
and incubated for 24 hours with increasing concentrations of 17β-E2 (0 to
10 nM). Nuclear proteins were extracted and submitted to gel retardation
assays in order to determine Sp and Sox proteins binding activities on
COL2A1 gene. In some experiments, relative expression of Sp1/Sp3 or Sox-9
was inhibited by siRNAs strategies. Moreover, chromatin immunoprecipi-
tation was used to study protein-protein interactions on COL2A1 promoter
and enhancer sequences.
Results: We have previously shown that 17β-E2 could stimulate type II
collagen neosynthesis, protein level and corresponding steady-state levels
of COL2A1 mRNAs in primary and in vitro dedifferentiated rabbit artic-
ular chondrocytes. 17β-E2 action was mediated, in part, by an ERα/Sp
transactivating effect on the -266/-63 bp region of COL2A1 proximal pro-
moter. Our new data showed that 17β-E2 also increases the DNA-binding
activities of Sp1/Sp3 and Soxs proteins to the ﬁrst intron region including
COL2A1 speciﬁc enhancer. In addition, Sp1, Sp3 and Sox-9 siRNAs prevented
hERα66-induced transactivation of COL2A1, suggesting that these factors
are required for COL2A1 up-regulation. Moreover, chromatin immunopre-
cipitation assays indicated that ERα physically interacts in vivo with Sp1,
Sp3, Sox-9 and p300 transcription factors, on both COL2A1 promoter and
enhancer sequences. Thus, considering that all these transcription factors
are known to act in concert, we proposed that 17β-E2 in vivo effect
could be mediated by a bridging complex, composed of ERα, Sp1, Sp3,
Sox-9 and p300 transcription factors, which could establish a physical link
between the two main cisregulatory regions of the gene, and consequently,
may facilitate COL2A1 transcription process. Besides, this transcriptional
activation of COL2A1 gene requires the ERα transactivation domains, AF-1
and AF-2, as demonstrated by using ERα mutants lacking these functional
domains.
Conclusions: Understanding the molecular basis for 17β-E2/ERα induction
of COL2A1 transcription provides new insights into molecular mechanisms
of OA and could be therefore attractive for some applications in the tissue
engineering of cartilage.
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IN VITROMODEL FOR CALCITONIN AS A COMBINATION THERAPY FOR
OSTEOARTHRITIS
N. Mehta, J. Gilligan
Unigene Lab. Inc., Fairﬁeld, NJ
Purpose: The study was designed to ﬁnd synergistic effects of salmon
calcitonin (sCT) with reference treatments for (osteo)arthrits in the bovine
cartilage explant model in which degradation is induced by a cocktail of
three cytokines.
Methods: Matrix degradation was quantiﬁed by measuring proteoglycan
release, collagen release and MMP activity. The pro-inﬂammatory molecule
PGE2 was also measured.
In the ﬁrst experiment maximum ineffective concentrations of sCT,
Galardin, Celebrex, Dexamethasone, BB-94 and Doxycyclin were deter-
mined. In the second experiment, combinations of sCT with each of the
other drugs were assayed to determine if there was a statistically signiﬁcant
synergistic effect of the combination
Results: Calcitonin (0.5 nM) and Doxycyclin (10 μM) alone had a no effect
on collagen release. They change the collagen release from 135 to 133 and
125 ng CTX-II per mg cartilage respectively. The combination, however,
decreased the collagen release to 73 ng CTX-II per mg cartilage. This effect
is stronger then expected based on the effects of
the compounds alone and is therefore synergistic.
A similar effect is observed for the combination of Calcitonin (0.5 nM) with
BB-94 (10 nM). Alone they change the collagen release from 135 to 133
and 137 ng CTX-II per mg cartilage respectively, while the combination
reduced the collagen release to 88 ng CTX-II per mg cartilage.
Although no synergy of sCT with the other compounds was detected in
this study, further experiments to determine a more appropriate range of
concentrations of each of the compounds needs to be carried out.
Conclusions: The combination of sCT with with doxycyclin and BB-94
can act synergistically to reduce type II collagen degradation in a bovine
cartilage explant model. These results lend support to the concept that a
combination therapy to reduce matrix degradation in OA can be developed
with very low doses of each of the compounds. Such a combination
therapy has the potential to alleviate the safety concerns with high doses
of doxycyclin or BB-94.
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HEALTHY MINDS, HEALTHY JOINTS: DEFINING A NOVEL ROLE FOR BACE1
IN CARTILAGE EROSION
M. Tortorella1 , A. Tomasselli2, L. Song2, R. TenBrink2, C. Anglin2,
A.-M. Malfait3
1Guangzhou Inst. of Biomedicine and Hlth., Guangzhou, China; 2Pﬁzer, St.
Louis, MO; 3Rush Med., Chicago, IL
Purpose: The role of aspartyl proteases in osteoarthritis has been rela-
tively unexplored. BACE-1 is an aspartic-acid protease important in the
pathogenesis of Alzheimer’s disease and in the formation of myelin sheaths
in peripheral nerve cells. BACE-1 is currently a target for therapeutic
intervention in neural degenerative diseases and the goal of these studies
was to explore its role in cartilage metabolism.
Methods: Selective small molecule inhibitors of BACE-1 were tested for
their ability to block cartilage breakdown in various pre-clinical assays.
Results: In these studies selective inhibition of BACE with various small
molecules blocked the cytokine induced glycosaminoglycan release in
both bovine and human cartilage explant cultures. Furthermore, immuno-
staining of human OA cartilage sections showed that BACE-1 protein was
localized in areas of cartilage undergoing matrix breakdown and ﬁbrillation.
Gene expression proﬁling suggested that the effect of BACE inhibition is
partly through the regulation of MMP13 message. Finally, BACE-1 null mice
are currently being analyzed for resistance to cartilage erosion in a surgical
instability model of OA.
Conclusions: These ﬁndings identify a novel role for BACE-1 in carti-
lage breakdown, raising the possibility that BACE-1 inhibitors will act as
therapeutics not only in Alzheimer’s, but in arthritic diseases as well.
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LAMA4 IS EXPRESSED BY CLUSTERS OF HYPERTROPHIC CHONDROCYTES
IN OSTEOARTHRITIC CARTILAGE AND REGULATED BY EPIGENETIC
MECHANIMS
F.C. Fuerst1, M.H. Stradner1, G. Gruber2, H. Angerer1, G. Hofmann1,
M. Kremser1, D. Setznagel1, A. Leithner2, W.B. Graninger1
1Med. Univ. Graz, Graz, Austria; 2Univ. Clinic for Orthopedic Surgery, Graz,
Austria
Purpose: Hypertrophic chondrocytes release proteinases resulting in a loss
of extracellular matrix compounds in osteoarthritis (OA. In the search
for molecular mechanisms leading to chondrocyte hypertrophy epigenetic
events have been discussed. In a genome-wide methylation analysis we
identiﬁed a consistent hypomethylation of the gene coding for the integrine
LAMA4 in OA chondrocytes
Methods: We obtained 15 samples of human osteoarthritis cartilage
during total knee joint replacement. Immunohistochemistry for LAMA4
was performed after histological grading for OA according to the OARSI
score. Isolated chondrocytes were cultured in the presence of 5-AZA-
deoxy-cytidine and expression of LAMA4 was quantiﬁed using the Taqman
Realtime PCR Assay.
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Results: All specimens with OA Grade III or IV stained for LAMA4, in
particular in the clusters of hypertrophic chondrocytes. Lower grades of
OA had no intracellular staining for LAMA4. The results of the Taqman PCR
revealed, that 5-AZA-deoxycytidine treatment led to an increase of LAMA4
expression in grade 0-II OA chondrocytes, whereas this was not the case in
grade III and IV chondrocytes.
Conclusions: Our results indicate that the integrine LAMA4 plays a role in
the hypertrophy of chondrocytes and that demethylation is the activating
process. Further investigations are needed to investigate the function of
LAMA4 in cartilage degeneration.
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POTENTIAL INVOLVEMENT OF GALECTIN-3 ON THE OSTEOARTHRITIC
HUMAN CHONDROCYTE PHENOTYPE
P. Reboul, F. Cailotto, P. Netter, A. Bianchi, J.-Y. Jouzeau
Univ. of Nancy 1, Vandoeuvre lès Nancy, France
Purpose: Osteoarthritis (OA) accounts for 40 to 60% of degenerative ill-
nesses of the musculoskeletal system. On the whole, approximately 15% of
the population suffers from OA. Of this number approximately 65% are 60
years of age and over. The high incidence of this illness is rather disturbing
since its frequency increases gradually with the aging of the population.
The end point of OA is cartilage destruction, which impairs joint move-
ment and causes pain. Joint destruction is also associated with joint
inﬂammation, where the synovial membrane plays a key role. Synovitis
induces alterations in chondrocyte function by the effects of inﬂamma-
tory cytokines, the presence of reactive oxygen species. Synovitis also
generates cycles of normoxia/hypoxia and enhances angiogenesis. Among
other several factors, galectin-3 (gal-3) can be markedly present in OA
synovial tissue and secreted in synovial ﬂuid during inﬂammatory phases.
We have recently shown that extracellular gal-3 induced proteoglycan
loss as well as MMP3 and ADAMTS5 increase whereas intracellular gal-3
protected chondrocytes from cell death. Pursuing our aim in deciphering
the extracellular gal-3 roles on chondrocytes, we investigated whether
gal-3 could modify chondrocyte phenotype. Recent works demonstrated
that in addition to the classical well known chondrocyte markers, Ankh
a PPi transporter, and estrogen receptor-related receptor alpha are also
involved in chondrocyte phenotype. In addition, S100A9, a calcium binding
protein having inﬂammatory properties when it is secreted, modiﬁed the
chondrocyte phenotype. However its intracellular function is not yet known
in chondrocyte. Therefore we evaluated these markers as well as type X
collagen and gal-3, known as hypertrophic markers.
Methods: Human OA chondrocytes (n=5), were incubated with rh-gal-3
under normoxic or hypoxic conditions for 24 and 72 hours and genes of
interest were assessed by real-time RT-PCR.
Results: Our results showed that Ankh and ERR alpha were slightly in-
creased by 135% and 140% respectively, when hypoxic conditions were
applied for 72h. Gal-3 (5 microg/ml) stimulated weakly (by 155%) hypoxic
induced-Ankh expression whereas ERR alpha expression was not modiﬁed
by gal-3. S100A9 and type X collagen were down-regulated by 80% and
25% respectively by hypoxia and gal-3 counteracted this effect when the
chondrocytes were incubated for 72h. Of note, the stimulation of S100A9
expression is far away from the one induced by interleukin-1 beta, which
might suggest in the present case an intracellular role of S100A9 rather
than a cytokine role. Finally, gal-3 stimulated its own expression (by 165%)
during the 72h hypoxic conditions.
Conclusions: Gal-3 had higher effects during the 72h incubation versus
the 24h one. Under the hypoxic conditions, gal-3 tended to stimulate
hypertrophic markers which are also induced during OA. Interestingly,
S100A9 presented the same pattern of regulation as type X collagen. One
hypothesizes that the gal-3-induced S100A9 might regulate intracellular
functions involved in the human chondrocyte phenotype changes occurring
during OA.
270
SIGNALING PATHWAY TO MATRIX METALLOPTROTEINASE-13
EXPRESSION IN IL-1β-TREATED CHONDROCYTES, SW1353 CELLS
H. Kim, H. Lim
Kangwon Natl. Univ., Chunchon, Korea, Republic of
Purpose: Matrix metalloproteinase-13 (MMP-13, mammalian collagenase)
is one of pivotal enzymes to degrade cartilage matrix on certain pathological
condition such as osteoarthritis. MMP-13 inhibitors and/or down-regulators
may show some beneﬁcial effects on arthritic diseases. Here, to establish
the signaling pathway to MMP-13 induction, effects of MAPK pathway and
the possibility of some other signaling pathways involved are investigated
in human chondrosarcoma cell line, SW1353 cells.
Methods: SW1353 cells were cultured and treated with IL-1β. MMP-13
and signaling molecules including MAPKs were detected with Western
blotting and RT-PCR analysis. Activation of transcription factors such as
NF-κB and AP-1 was determined by EMSA. siRNA transfection study for
STAT involvement was also carried out.
Results: When IL-1β (10 ng/ml) was treated, SW1353 cells strongly induced
MMP-13 with concomitant activation of NF-κB, AP-1 and MAPKs including
ERK, p38 MAPK and JNK. Among these MAPKs, only p38 MAPK inhibitor
(SB203580) blocked MMP-13 induction and AP-1 activation in IL-1β-treated
SW1353 cells. SB203580 also inhibited c-Fos translocation to the nucleus
(but not c-Jun). Most importantly, it was also found that IL-1β treatment
provoked JAK2 activation as well as STAT1/2/3 activation. JAK2 inhibitor
(AG-490) blocked STAT1/2 activation as well as MMP-13 induction in
IL-1β-treated SW1353 cells.
Conclusions: Through the concerted action of these transcription factors,
NF-κB, AP-1 and STATs, MMP-13 may be induced in IL-1β-treated chon-
drocytes. An interference of these crucial signaling pathways may possibly
show chondroprotective effect in cartilage degenerative diseases.
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INHIBITION OF HYDROGEN PEROXIDE-INDUCED OXIDATIVE STRESS TO
CHONDROCYTES BY THE COMBINATION OF AVOCADO/SOYBEAN
UNSAPONIFIABLES AND EPIGALLOCATECHIN GALLATE
K.N. Powell1, A.Y. Au1,2, L.F. Heinecke1, M.W. Grzanna1, S.L. Ownby1,
A.M. Rashir-Raven3, C.G. Frondoza1,4
1Nutramax Lab., Inc., Edgewood, MD; 2Syracus Univ., Syracuse, NY; 3Michigan
State Univ., East Lansing, MI; 4Johns Hopkins Univ., Baltimore, MD
Purpose: The present study determined whether hydrogen peroxide (H2O2)
induction of inﬂammation and oxidative stress markers can be inhibited by
the combination of avocado/soybean unsaponiﬁables (ASU) and the green
tea component epigallocatechin gallate (EGCG). ASU is reported to exert
anti-inﬂammatory activity whereas EGCG is both anti-inﬂammatory and
antioxidant.
Oxidative stress has been proposed to play a role in aging as well as
in the pathogenesis of osteoarthritis (OA). It is associated with excess
production of reactive oxygen species (ROS) by tissue cells. There is also
ineffective detoxiﬁcation of ROS. Oxidative stress is thought to be coupled
with inﬂammation suggested by generation of ROS by pro-inﬂammatory
mediators. The generation of ROS can be triggered in articular cartilage
chondrocytes by cytokines, prostaglandins, and nitric oxide (NO). Elevated
concentrations of ROS inﬂict damage to DNA, proteins, and subcellular
structures resulting in cell death by apoptosis. Hydrogen peroxide (H2O2)
is an ROS known to induce oxidative stress in cultured tissue cells. H2O2
also inhibits proteoglycan synthesis, causes chondrocyte apoptosis and
facilitates cartilage degradation.
Methods: Equine chondrocyte cultures were preincubated at 37°C, 5% CO2
with: (i) control media alone, (ii) known antioxidant N-acetyl cysteine
(NAC, 10 mM), or (iii) combination of ASU (ASU®-NMX1000, 8.3 μg/ml)
and EGCG (4 or 40 μg/ml) for 24 hrs. Chondrocytes were next exposed
to 100-4000 μM H2O2 for 1-24 hrs. Production of PGE2 and NO were
measured by ELISA and the nitrite Griess reagent respectively. Apoptosis
was assessed by microscopic analysis of: (a) annexin V/propidium iodide
(PI) staining using the Vybrant® Apoptosis Assay Kit and (b) caspase 3
activity using Apo-ONE® Homogeneous Capase-3/7 Assay (Promega). Data
was analyzed using one-way ANOVA, Tukey post-hoc at p<0.05 level of
signiﬁcance.
Results: PGE2 production in chondrocyte cultures signiﬁcantly increased
after exposure to ≥300 μM H2O2 for 24 hrs. In contrast, NO produc-
tion was detectable only after exposure to 4000 μM H2O2. Dose- and
time-dependent cytotoxicity induced by H2O2 was identiﬁed by PI nuclear
staining. Approximately 40-50% of chondrocytes were dead after 3 hrs
of exposure to 500 μM H2O2. Chondrocytes displayed a rounded, granu-
lar appearance and eventually detached. Annexin staining in the plasma
membrane was observed following 1-3 hrs of incubation with 300-4000
μM of H2O2, suggesting apoptosis. Caspase 3 activity was also induced
by at least 50% with 300 μM of H2O2. Pre-incubation of chondrocytes
